Coronavirus news LIVE updates: The number of new coronavirus infections reported in a span of 24 hours was recorded below 20,000 after nearly six months while the COVID-19 active caseload fell below 3 lakh, according to the Union Health Ministry data updated on Tuesday. India’s COVID-19 caseload rose to 1,00,75,116 with19,556 new infections being reported in a day. The death toll increased to 1,46,111 with 301 new fatalities, the data updated at 8 am showed.The number of people who have recuperated from the disease surged to 96,36,487 pushing the national recovery rate to95.65 percent, while the COVID-19 case fatality rate stands at 1.45 percent. The COVID-19 active caseload has fallen below 3 lakh.There are 2,92,518 active coronavirus infections in the country whichcomprises2.90per cent of the total caseload, the data stated. India’s COVID-19 tally had crossed the 20-lakh mark on August 7,30 lakhonAugust 23, 40 lakh on September 5 and50 lakh on September 16. It went past60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.According to the ICMR,16,31,70,557 samples have been tested up to December 21 with 10,72,228 samples being tested on Monday.
Coronavirus News LIVE updates: Nine new cases take Mizoram’s COVID-19 tally to 4,133
Nine more people, including an eight-year-old girl, tested positive for COVID-19 in Mizoram on Tuesday, taking the tally in the state to 4,133, a health department official said. Of the fresh cases, four were reported from Aizawl, three from Lawngtlai and one each from Lunglei and Kolasib districts, he said. Five new patients have travel history, while three were detected during contact tracing and it is yet to be ascertained how the remaining one person contracted the disease, the official said, adding that they were asymptomatic. Mizoram now has 153 active cases, while 3,973 people have recovered from the disease so far and seven died.
Coronavirus News LIVE updates: New COVID strain will not jeopardise England tour of Sri Lanka, says SLC
The new strain of COVID-19 that has hit the United Kingdom will not jeopardise England’s upcoming tour of Sri Lanka even though the development is a cause of concern, the country’s cricket board (SLC) said on Tuesday. Sri Lanka Cricket’s (SLC) medical team feels that the tour starting January 14 is on schedule but additional COVID-19 protocols might be enforced for the visitors either before leaving their country or after arriving here.
Coronavirus News LIVE updates: Amritsar: 7 passengers, crew member on flight from UK test positive for COVID
Seven passengers and a crew member who arrived here from the UK in an Air India flight tested positive for coronavirus on Tuesday. Punjab Minister for Medical Education and Research O P Soni said those who tested positive for the infection will be quarantined. Among the infected passengers are six men and two women, he said. The Air India flight from London had landed at Amritsar’s Sri Guru Ramdas Jee International Airport with 250 passengers and 22 crew members at 12.30 am last night.
Coronavirus News LIVE updates: 402 new COVID-19 cases in AP, four deaths
Andhra Pradesh’s COVID-19 tally rose to 8,79,339 as 402 fresh cases were added on Tuesday. In 24 hours ending 9 am on Tuesday, the state reported 412 more recoveries and four deaths. A health department bulletin said the total recoveries increased to 8,68,279 and deaths to 7,082, leaving 3,978 active cases. Chittoor and Krishna districts continued to report a high caseload with the addition of 86 and 72 fresh cases in a day.
Coronavirus News LIVE updates: Ocugen and Bharat BioTech to co-develop COVAXIN for the US market
Ocugen, a biopharmaceutical co & Bharat Biotech have signed a binding letter of intent (LOI) to co-develop Bharat Biotech’s #COVID19 vaccine candidate, COVAXIN, an advanced stage whole-viron inactivated vaccine candidate, for the United States market. pic.twitter.com/PbL4i7mzjp
— CNBC-TV18 (@CNBCTV18Live) December 22, 2020
Coronavirus News LIVE updates: COVID-19 testing facility set up at Kempegowda International Airport in Bengaluru
The Bangalore International Airport Limited (BIAL) has launched a round-the-clock COVID-19 testing facility at the Kempegowda International Airport here. Located near the arrivals area of the terminal, the NABL and ICMR certified RT-PCR testing centre is managed and operated by Bengaluru-based Auriga Research Private Limited, BIAL said in a statement. BIAL has launched a round-the-clock COVID-19 testing facility at the Kempegowda International Airport here. Located near the arrivals area of the terminal, the NABL and ICMR certified RT-PCR testing centre is managed and operated by Bengaluru-based Auriga Research Private Limited, BIAL said in a statement.
Coronavirus News LIVE updates: Scientists say UK strain unlikely to affect efficacy of COVID-19 vaccines, warn against more mutations
The faster spreading coronavirus strain first detected in the UK is unlikely to make vaccines less effective as of now but the preventives may need to be appropriately altered if more mutations occur over time, say scientists. More than 40 countries, including India, have banned travel to and from the UK, a move several scientists said was necessary in view of the rapid spread of the new viral strain, VUI-202012/0, that was detected on September 21. According to Jeremy Farrar, director of the London-based research charity Wellcome Trust UK, there is no indication at the moment that the new strain would evade treatments and vaccines. However, the mutation is a reminder of the power of the virus to adapt, and that cannot be ruled out in the future. Acting urgently to reduce transmission is critical, Farrar said in a statement.
COVID-19 vaccine update: SEC to meet soon on Pfizer, SII’s emergency use application, say sources
Subject Expert Committee (SEC) will meet soon to take up the application of Pfizer and SII for emergency use authorization (EUA) for their COVID-19 vaccine candidates. Pfizer has written to the drug controller seeking fresh date to present their case for EUA for its COVID-19 vaccine. Pfizer was the first to apply for EUA in India on December 5. However, on the day of presentation, Pfizer sought time from SEC as its experts were busy and could not present their case. SEC will also take up SII case for COVISHIELD in the same meeting. SEC has asked SII to first conduct phase 2 trials of COVOVAX in India. SII had sought permission from SEC to conduct phase III trials in India, it had already conducted Phase I and II trials in the US.
So far, new coronavirus strain not seen in India: Government
The government on Tuesday said that the new ‘fast-spreading’ strain of Covid-19 has not been seen in India so far.Get latest Healthcare online at cnbctv18.com
Coronavirus News LIVE updates: No plan for vaccines for kids, sources to CNBC-TV18
Since the COVID-19 vaccine trials took place on adults, there is no plan in place for vaccine effective for kids, reports CNBC-TV18. “There are no guidelines generally for vaccinating children. It is by and large for higher age since the new vaccines have not been tested in the pediatric population,” said VK Paul, member of NITI Aayog. Based on evidence, there is no reason to consider vaccination of children, he added.
Coronavirus News LIVE updates: SII has submitted additional data that was sought for EUA: Sources to CNBCTV-18
Just in: Serum Institute of India (SII), India’s indigenous vaccine maker has submitted additional data demanded by subject matter experts for emergency use authorization. SEC had asked SII and Bharat BioTech to submit additional information and data on the trials for EUA in India. Experts have assured that the vaccines-in-development can treat the new strain of the virus as well.
Coronavirus News LIVE updates: Civil Aviation Minister Hardeep Puri to CNBC-TV18
— CNBC-TV18 (@CNBCTV18Live) December 22, 2020
Coronavirus News LIVE updates: Anyone with recent travel history to UK will be under surveillance, says Aviation Minister Puri
Civil Aviation Minister, Hardeep Puri told CNBC-TV18 in an interview that the government is monitoring the situation and will keep testing passengers coming in. He said anyone with recent travel history of the UK will be under surveillance. Speaking on the flight suspension to UK, Puri said these measures are temporary. UK Prime Minister is the Chief Guest of Republic Day events on January 26. The govt is confident that by Dec 31, India will be at pre-COVID levels in terms of air traffic. We will be at 300,000-350,000 daily air traffic by March 2021, Puri said. Govt is planning to increase the domestic capacity beyond 80 percent in the coming days. Speaking about the vaccine, Puri told CNBC-TV18 that authorization for emergency use of COVID-19 vaccine may come in India in a few weeks. All stakeholders are working on vaccine distribution.
Coronavirus News LIVE updates: No change in treatment guidelines due to new COVID-19 strain, says Paul
Government is not changing guidelines due to the new coronavirus strain, said NITI Aayog member, VK Paul. He added that vaccine development won’t be hampered by the new strain. “No need to panic, we are yet to spot this mutated virus in the country as of now. We need to be more vigilant and take precautions,” he added.
Coronavirus News LIVE updates: 17 mutations seen in the new COVID-19 strain, says VK Paul
VK Paul, member, NITI Aayog, said that the new coronavirus strain has developed 17 mutations, which has increased its infectiousness and transmissibility. However, he added that its severity is not impacted by the mutation. Indian labs are conducting genomic studies of various mutations in the virus. The new coronavirus strain was discovered in the UK yesterday. So far, 5 passengers who arrived from the UK to Delhi have tested positive for coronavirus. In the light of this development, other passengers were asked to home quarantine for 3 days. Govt has sent samples to check whether it is the new strain, there is no reason for anxiety, said Paul. He added that agency will review the suspension on UK flights in 5-6 days.
Coronavirus News LIVE updates: London returnee’s sample to go to NIV for genomic analysis
A passenger who arrived here from London via Delhi has tested positive for coronavirus and genomes from his sample would be analysed to see if it matched with the new strain of the pathogen detected in the United Kingdom, a senior official said here on Tuesday. The passenger, who tested positive has been admitted to the state-run King’s Institute of Preventive Medicine and Research here, Health Secretary J Radhakrishnan said. His sample would be sent for genomic analysis to National Institute of Virology, Pune for confirmation, he told reporters. “It has to be seen if it matches with that of the strain seen in the UK.” Also, over 1,000 passengers who arrived from the UK in the past about 10 days were being monitored for symptoms. All international passengers, on arrival, were being tested for coronavirus and they have been advised home or institutional quarantine for 14 days as per guidelines, he said.
Govt issues new SOPs for international travellers amid concerns over new COVID strain
In the light of the new coronavirus strain discovered in the UK, the Indian government has issued fresh guidelines for all international travellers who have travelled from or transited through the UK…
Coronavirus News LIVE updates: Rakul Preet Singh tests positive for COVID-19
Actor Rakul Preet Singh on Tuesday said she has been diagnosed with COVID-19 and is currently in quarantine. Singh was shooting for actor Ajay Devgn’s directorial “Mayday” in Hyderabad. Taking to Twitter, the 30-year-old actor said she is “feeling fine” and urged all those who came in her contact to get tested. “I’d like to inform everyone that I have tested positive for COVID-19. I have quarantined myself. I am feeling fine and will rest up well so that I can be back at shoot soon. “Request everyone who met me to kindly get yourself tested. Thank you and please stay safe,” she wrote.
Coronavirus News LIVE updates: Chhaptrapati Shivaji Maharaj International Airport announces resulting changes for the passengers travelling via the airport
Effective 23:59 hrs Dec 22 until 23:59 hrs on Dec 31: All flights to and from the United Kingdom are suspended temporarily. Effective, Dec 22, Passengers arriving from the Middle East and European countries, irrespective of their further travel plans, will be subjected to mandatory institutional quarantine; any passenger identified as being symptomatic on arrival will be transferred to designated COVID facility for further evaluation. Passengers arriving from these regions will be transported by state officials to nearby hotels of their preference to undergo institutional quarantine for seven days at their own cost. Effective, Dec 22 until Jan 5, With regard to the night curfew from 23:00 hrs to 06:00 hrs, all operations at CSMIA will continue as scheduled. Passengers travelling to and from the airport during the specified hours will be allowed to proceed onwards as cab services and public transportation will remain operational at all time.
Coronavirus News LIVE updates: Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of Covaxin
Bharat Biotech on Tuesday announced the recruitment of 13,000 volunteers and continued progress towards achieving the goal of 26,000 participants for the Phase III clinical trials of its COVID-19 vaccine ’Covaxin’ across multiple sites in India. Covaxin has been evaluated in approximately 1,000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity results, Bharat Biotech said in a statement. The indigenously developed COVID-19 vaccine has been developed in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV), it added. ”Covaxin is a highly purified and inactivated 2 dose SARS-CoV2 vaccine, manufactured in a vero cell manufacturing platform with an excellent safety track record of more than 300 million doses,” Bharat Biotech said.
Coronavirus News LIVE updates: Vaccine-induced immunity is protective against the new COVID-19 strain, says Moderna
COVID-19 vaccine manufacturer Moderna said that based on data, they expect vaccine-induced immunity to be protective against the new COVID-19 strain. Healthcare experts in the UK discovered a new coronavirus strain in the UK yesterday which is said to be more contagious than the existing strain. “We will be performing additional tests in the coming weeks to confirm this expectation,” it said.
Coronavirus news LIVE updates: Govt issues guidelines for international travellers in the light of new coronavirus strain found in the UK
— CNBC-TV18 (@CNBCTV18Live) December 22, 2020
Coronavirus news LIVE updates: Odisha reports 319 new COVID-19 cases, 4 fresh fatalities
Odisha’s COVID19 tally rose to 3,26,915 on Tuesday as 319 more people tested positive for the infection, while four fresh fatalities pushed the state’s coronavirus death toll to 1,843, a health official said. As many as 184 new cases were reported in quarantine centres, while the remaining fresh infections were detected during contact tracing, he said.
Coronavirus news LIVE updates: Two passengers from UK test positive for COVID-19 at Kolkata airport
Two passengers from the UK were found positive for COVID19 after they arrived at the airport here, health department officials said on Tuesday. A flight carrying 222 passengers from the UK arrived at Netaji Subhas Chandra Bose International (NSCBI) airport on Sunday night, they said.
Coronavirus news LIVE updates: Six passengers on London-Delhi flight test positive for COVID-19
Six passengers travelling on Air India’s London Delhi flight tested positive for COVID19 on arrival, a senior government official said on Tuesday. The flight landed around 11.30 pm on Monday.
Coronavirus news LIVE updates: Vaccine bond sales to soar to fund COVID-19 shots for poor countries
Socially conscious bond investors will be targeted in a coming wave of vaccine bond deals that will seek to provide billions of dollars for the speedy rollout of COVID19 shots for developing countries.
Coronavirus news LIVE updates: Arunachal Pradesh reports 22 new COVID-19 cases, one more fatality
At least 22 more people tested positive for COVID19 in Arunachal Pradesh, pushing the tally in the northeastern state to 16,652, a health department official said on Tuesday. The death toll rose to 56 after a 50yearold coronavirus patient died at a hospital in Tawang district on Monday, State Surveillance Officer (SSO) Dr Lobsang Jampa said.
Coronavirus news LIVE updates: Indian COVID-19 vaccine maker says recruitment for trials on track
The maker of one of India’s leading COVID19 vaccine candidates said on Tuesday its recruitment of volunteers for a latestage trial of the shot was on track, following reports of a shortage of participants.
Coronavirus news LIVE updates: South Korea shuts ski resorts, winter tourism to curb COVID-19 spread
South Korea on Tuesday moved to shut down all ski resorts and winter tourist spots in a bid to stop the novel coronavirus spreading as a third wave of the pandemic proves much tougher to contain in the densely populated region around the capital city.
Coronavirus news LIVE updates: 349 new COVID-19 cases in Thane; tally reaches 2,39,280 in Maharashtra
With the addition of 349 new COVID19 cases, the tally in Maharashtra’s Thane district has gone up to 2,39,280, an official said on Tuesday. Six more people also succumbed to the viral infection in the district, raising the toll to 5,884, he said.